OA4-4 Latency reversing agents induce HIV-1 protein expression in latently infected cells for cytotoxic T-lymphocyte antiviral recognition and killing

by A. Ruiz, E. Jimenez, R. Peña, P. Goulder, B. Clotet, J.G. Prado
Published 2016-07-01

CD8+ sensing relies on nanomolar levels of antigen presented upon HIV-1 reactivation

by A. Ruiz, E. Jimenez, R. Peña, P. Goulder, B. Clotet, J.G. Prado
Published 2015-12-01

Nef genotype influences immune control in individuals living with HIV-1 who carrying protective alleles

by F. Method Mwimanzi, I. Ngare, M. Mori, J. Mann, P. Goulder, T. Ndung’u, T. Ueno
Published 2019-07-01

20 Rapid CTL recognition of HIV-1 latently infected cells depends on the levels of inducible viral reactivation and CTL activation status

by A. Ruiz, O. Blanch-Lombarte, E. Jimenez-Moyano, R. Peña, M. Genescà, P. Goulder, B. Clotet, J.G. Prado
Published 2017-07-01

18 Initiation of ART within 24–48 hours of birth following in utero HIV infection: the Ucwaningo Lwabantwana Study

by J. Roider, B.P. Mbatha, D. Hlope, M. Muenchhoff, K. Sprenger, Y. Graza, J. Lobenstein, van, R. Bhoola, M. Krishna, K. Spicer, T. Ndung’u, P. Goulder
Published 2016-07-01

Unmet needs of highrisk mothers reduce success of antiretroviral treatment in HIVinfected infants

by Z Mvo, V Ntlantsana, N Bengu, J Millar, J Roider, R Bhoola, M Krishna, Y Graza, J van Lobenstein, C Kapongo, C Kogielambal, K Sprenger, M Archary, T Ndung'u, P Goulder
Published 2018-07-01